Related Experiment Video
Updated: Jul 4, 2026
08:16
Comparative Lesions Analysis Through a Targeted Sequencing Approach
Published on: November 5, 2019
Human tumour clonality assessment--flawed but necessary.
1Histopathology Laboratory, Cancer Research UK, London Research Institute, 44 Lincoln's Inn Fields, London, UK. simon.leedham@cancer.org.uk
The Journal of Pathology
|June 21, 2008
Summary
Tumours originate from a single mutated cell. Identifying the founding mutation is crucial for accurate cancer clonality studies, though challenges remain in establishing these in many human organs.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- The somatic mutation theory of carcinogenesis posits that tumors arise from a single mutated stem cell.
- Numerous studies have investigated tumor clonality using various molecular markers across different organs.
Purpose of the Study:
- To review the advantages, disadvantages, and applications of different clonality markers in cancer research.
- To highlight the importance of identifying founding mutations for accurate clonality assessment.
Main Methods:
- Review of existing literature on clonality studies in carcinogenesis.
- Analysis of different molecular markers used to determine tumor clonality.
- Discussion of challenges in establishing founding mutations.
Main Results:
- Clonality studies are essential for understanding tumor development and evolution.
- Identifying the founding mutation is critical for true clonality assessment, distinguishing it from sub-clones.
- Current methods have limitations, particularly in establishing founding mutations in many human organ systems.
Conclusions:
- Accurate clonality assessment, based on founding mutations, is fundamental for constructing cancer phylogenetic trees.
- Further research is needed to overcome challenges in identifying founding mutations across diverse human organs.
